These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17866361)

  • 1. THE USE OF PERFRINGENS ANTITOXIN IN INTESTINAL OBSTRUCTION: AN EXPERIMENTAL STUDY.
    North JP
    Ann Surg; 1930 Aug; 92(2):277-80. PubMed ID: 17866361
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF BACILLUS WELCHII (PERFRINGENS) ANTITOXIN IN EXPERIMENTAL GENERAL PERITONITIS AND INTESTINAL OBSTRUCTION.
    Copher GH; Stone CS; Hildreth HR
    Ann Surg; 1929 May; 89(5):641-6. PubMed ID: 17866091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of the methods of determining perfringens A antitoxin].
    Shemanova GF; Trapezov EV; Musina EE; Vlasova EV; Panteleev EI
    Biull Eksp Biol Med; 1983 Nov; 96(11):82-4. PubMed ID: 6315110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN).
    EVANS DG; PERKINS FT
    Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with gas gangrene antitoxin and recombinant human soluble thrombomodulin for Clostridium perfringens sepsis in a rat model.
    Hifumi T; Nakano D; Chiba J; Takahashi M; Yamamoto A; Fujisawa Y; Kawakita K; Kuroda Y; Nishiyama A
    Toxicon; 2018 Jan; 141():112-117. PubMed ID: 29246581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASSAY OF POTENCY OF THE PROPOSED FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS).
    PRIGGE R; MICKE H; KRUEGER J
    Bull World Health Organ; 1963; 29(6):737-43. PubMed ID: 14107746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha antitoxin content of the international reference preparations of Clostridium welchii types B and D antitoxins.
    SKULBERG A; VAN HEYNINGEN WE
    Bull World Health Organ; 1956; 14(3):557-66. PubMed ID: 13342930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of a depot substance on Clostridium perfringens antitoxin production in the condition of total body irradiation].
    KOVTUNOVICH LG
    Med Rev; 1961 Aug; 6():72-4. PubMed ID: 15445321
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental studies on serum treatment and vaccination against Cl. perfringens type C infection in piglets.
    Hogh P
    Dev Biol Stand; 1976; 32():69-76. PubMed ID: 187513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterotoxemia of sheep. III. Clostridium perfringens type D antitoxin titers of normal, nonvaccinated lambs.
    GRINER LA
    Am J Vet Res; 1961 May; 22():447-8. PubMed ID: 13708763
    [No Abstract]   [Full Text] [Related]  

  • 11. A chicken intestinal ligated loop model to study the virulence of Clostridium perfringens isolates recovered from antibiotic-free chicken flocks.
    Parent E; Archambault M; Charlebois A; Bernier-Lachance J; Boulianne M
    Avian Pathol; 2017 Apr; 46(2):138-149. PubMed ID: 27917645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the in vitro neutralization test of Clostridium perfringens type A toxin.
    Shemanova GF; Vlasova EV; Postnikova TM
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):219-26. PubMed ID: 2900852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Clostridium welchii in strangulation obstruction.
    COHN I; HAWTHORNE HR
    Ann Surg; 1951 Dec; 134(6):999-1006. PubMed ID: 14895126
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens type-D enterotoxaemia in cattle: the diagnostic significance of intestinal epsilon toxin.
    Jones AL; Dagleish MP; Caldow GL
    Vet Rec; 2015 Oct; 177(15):390. PubMed ID: 26428898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of PCR and DNA sequencing for direct detection of Clostridium perfringens in the intestinal tract of broilers.
    Henriksen M; Bisgaard M; Francesch M; Gabriel I; Christensen H
    Avian Dis; 2009 Sep; 53(3):441-8. PubMed ID: 19848086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colostral transfer of Clostridium perfringens type C beta antitoxin in swine.
    Matisheck PH; McGinley M
    Am J Vet Res; 1986 May; 47(5):1132-3. PubMed ID: 2872843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allicin as feed additive to enhance vaccination capacity of Clostridium perfringens toxoid in rabbits.
    Abu El Hammed W; Soufy H; El-Shemy A; Nasr SM; Dessouky MI
    Vaccine; 2016 Apr; 34(17):2000-7. PubMed ID: 26973070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous lysozyme influences Clostridium perfringens colonization and intestinal barrier function in broiler chickens.
    Liu D; Guo Y; Wang Z; Yuan J
    Avian Pathol; 2010 Feb; 39(1):17-24. PubMed ID: 20390532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus subtilis and yeast cell wall improve the intestinal health of broilers challenged by Clostridium perfringens.
    Li Z; Wang W; Lv Z; Liu D; Guo Y
    Br Poult Sci; 2017 Dec; 58(6):635-643. PubMed ID: 28841050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.